Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stem Cell Research

This article was originally published in RAJ Devices

Executive Summary

US president vetoes bill to expand federal funding for stem cell research

US president vetoes bill to expand federal funding for stem cell research

US President George W Bush has vetoed the Stem Cell Research Enhancement Act of 2007, which would have expanded federal funding of embryonic stem cell research to include surplus embryos donated from fertility clinics1. On the same day, President Bush issued an executive order directing the Department of Health and Human Services to explore ways of deriving pluripotent stem cell lines that do not involve destroying human embryos2.

Last year, President Bush vetoed an earlier version of the legislation, and Congress was unable to gather the two-thirds majority required to override that veto3. The latest version was approved by the Senate in April 2007 and by the House of Representatives in June4,5. Representative Mike Castle (Republican - Delaware), one of the sponsors of the House bill, has announced that he and several other Republicans intend to vote to override the president's latest veto, although there are concerns that the measure lacks the necessary votes in the House6.

References

1. Message to the Senate of the United States, 20 June 2007, www.whitehouse.gov/news/releases/2007/06/20070620-5.html

2. Executive Order: Expanding Approved Stem Cell Lines in Ethically Responsible Ways, 20 June 2007, www.whitehouse.gov/news/releases/2007/06/20070620-6.html

3. The Regulatory Affairs Journal - Pharma, 2006, 17(8), 554-555

4. The Regulatory Affairs Journal - Devices, 2007, 15(3), 208

5. Representative Castle press release, 7 June 2007, www.castle.house.gov/index.php?option=com_content&task=view&id=421

6. Representative Castle press release, 20 June 2007, www.castle.house.gov/index.php?option=com_content&task=view&id=426

Latest Headlines
See All
UsernamePublicRestriction

Register

SC094489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel